These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 19707424)
1. Clinical uses of GM-CSF, a critical appraisal and update. Arellano M; Lonial S Biologics; 2008 Mar; 2(1):13-27. PubMed ID: 19707424 [TBL] [Abstract][Full Text] [Related]
2. Cytokines as Biomarkers for Evaluating Physical Exercise in Trained and Non-Trained Individuals: A Narrative Review. Małkowska P; Sawczuk M Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446334 [TBL] [Abstract][Full Text] [Related]
3. Emerging principles of cytokine pharmacology and therapeutics. Saxton RA; Glassman CR; Garcia KC Nat Rev Drug Discov; 2023 Jan; 22(1):21-37. PubMed ID: 36131080 [TBL] [Abstract][Full Text] [Related]
5. Formulation and In Vitro Characterization of PLGA/PLGA-PEG Nanoparticles Loaded with Murine Granulocyte-Macrophage Colony-Stimulating Factor. Mihalik NE; Wen S; Driesschaert B; Eubank TD AAPS PharmSciTech; 2021 Jun; 22(5):191. PubMed ID: 34169366 [TBL] [Abstract][Full Text] [Related]
6. Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models. McAusland TM; van Vloten JP; Santry LA; Guilleman MM; Rghei AD; Ferreira EM; Ingrao JC; Arulanandam R; Major PP; Susta L; Karimi K; Diallo JS; Bridle BW; Wootton SK Mol Ther Oncolytics; 2021 Mar; 20():306-324. PubMed ID: 33614913 [TBL] [Abstract][Full Text] [Related]
7. The protective effects of granulocyte-macrophage colony-stimulating factor against radiation-induced lung injury. Hu D; Zhang Y; Cao R; Hao Y; Yang X; Tian T; Zhang J Transl Lung Cancer Res; 2020 Dec; 9(6):2440-2459. PubMed ID: 33489805 [TBL] [Abstract][Full Text] [Related]
8. Anti-Tumor Effects of Vitamin B2, B6 and B9 in Promonocytic Lymphoma Cells. Mikkelsen K; Prakash MD; Kuol N; Nurgali K; Stojanovska L; Apostolopoulos V Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31374832 [TBL] [Abstract][Full Text] [Related]
9. A compact synthetic pathway rewires cancer signaling to therapeutic effector release. Chung HK; Zou X; Bajar BT; Brand VR; Huo Y; Alcudia JF; Ferrell JE; Lin MZ Science; 2019 May; 364(6439):. PubMed ID: 31048459 [TBL] [Abstract][Full Text] [Related]
10. Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. García-Martínez E; Smith M; Buqué A; Aranda F; de la Peña FA; Ivars A; Cánovas MS; Conesa MAV; Fucikova J; Spisek R; Zitvogel L; Kroemer G; Galluzzi L Oncoimmunology; 2018; 7(6):e1433982. PubMed ID: 29872569 [TBL] [Abstract][Full Text] [Related]
11. Cancer astrocytes have a more conserved molecular status in long recurrence free survival (RFS) IDH1 wild-type glioblastoma patients: new emerging cancer players. Franceschi S; Lessi F; Aretini P; Ortenzi V; Scatena C; Menicagli M; La Ferla M; Civita P; Zavaglia K; Scopelliti C; Apollo A; Carbone FG; Vannozzi R; Bevilacqua G; Pasqualetti F; Naccarato AG; Mazzanti CM Oncotarget; 2018 May; 9(35):24014-24027. PubMed ID: 29844869 [TBL] [Abstract][Full Text] [Related]
12. Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand? Marín E; Cuturi MC; Moreau A Front Immunol; 2018; 9():274. PubMed ID: 29520275 [TBL] [Abstract][Full Text] [Related]
13. Efficient Therapeutic Protein Expression Using Retroviral Replicating Vector with 2A Peptide in Cancer Models. Hofacre A; Yagiz K; Mendoza D; Lopez Espinoza F; Munday AW; Burrascano C; Singer O; Gruber HE; Jolly DJ; Lin AH Hum Gene Ther; 2018 Apr; 29(4):437-451. PubMed ID: 29216761 [TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for malignant pleural mesothelioma: current status and future directions. Dozier J; Zheng H; Adusumilli PS Transl Lung Cancer Res; 2017 Jun; 6(3):315-324. PubMed ID: 28713676 [TBL] [Abstract][Full Text] [Related]
15. Combinatorial drug delivery approaches for immunomodulation. Stewart JM; Keselowsky BG Adv Drug Deliv Rev; 2017 May; 114():161-174. PubMed ID: 28532690 [TBL] [Abstract][Full Text] [Related]
16. Neutrophils acquire the capacity for antigen presentation to memory CD4 Vono M; Lin A; Norrby-Teglund A; Koup RA; Liang F; Loré K Blood; 2017 Apr; 129(14):1991-2001. PubMed ID: 28143882 [TBL] [Abstract][Full Text] [Related]
17. Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity. Hu X; Liu X; Moisan J; Wang Y; Lesch CA; Spooner C; Morgan RW; Zawidzka EM; Mertz D; Bousley D; Majchrzak K; Kryczek I; Taylor C; Van Huis C; Skalitzky D; Hurd A; Aicher TD; Toogood PL; Glick GD; Paulos CM; Zou W; Carter LL Oncoimmunology; 2016; 5(12):e1254854. PubMed ID: 28123897 [TBL] [Abstract][Full Text] [Related]
18. Novel oncolytic viral therapies in patients with thoracic malignancies. Ahmad Z; Kratzke RA Oncolytic Virother; 2017; 6():1-9. PubMed ID: 28053943 [TBL] [Abstract][Full Text] [Related]